« Back Urologic Oncology: Seminars and Original Investigations

Article in Press

External validation of the cancer of the prostate risk assessment (CAPRA) score in a single-surgeon radical prostatectomy series

  • Stacy Loeb, M.D.

      Affiliations

    • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    • ,
  • Gustavo F. Carvalhal, M.D., Ph.D.

      Affiliations

    • Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    • ,
  • Donghui Kan, M.S.

      Affiliations

    • Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    • ,
  • Angel Desai, B.S.

      Affiliations

    • Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    • ,
  • William J. Catalona, M.D.

      Affiliations

    • Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-312-695-8146; fax: +1-312-695-1482.

Received 14 May 2010 ,Revised 6 June 2010 ,Accepted 10 June 2010. Published online 07 September 2010 Corrected Proof

References 

  1. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy vs. watchful waiting in early prostate cancer. N Engl J Med. 2005;352:1977–1984
  2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. Ca Cancer J Clin. 2008;58:71–96
  3. Albertsen PC, Hanley JA, Fine J. Twenty-year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005;293:2095–2101
  4. Partin AW, Yoo J, Carter HB, et al. The use of prostate specific antigen, clinical stage, and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 1993;150:110–114
  5. Shariat SF, Karakiewicz PI, Margulis V, et al. Inventory of prostate cancer predictive tools. Curr Opin Urol. 2008;18:279–296
  6. Eastham JA, Scardino PT, Kattan MW. Predicting an optimal outcome after radical prostatectomy: The Trifecta nomogram. J Urol. 2008;179:2207–2211
  7. Kattan MW, Cuzick CK, Fisher G, et al. Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. Cancer. 2008;112:69–74
  8. Kattan MW, Eastham JA, Stapleton AMF, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst. 1998;90:766–771
  9. Partin AW, Mangold LA, Lamm DM, et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology. 2001;58:843–848
  10. Shariat SF, Karakiewicz PI, Suardi N, et al. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: A critical analysis of the literature. Clin Cancer Res. 2008;14:4400–4407
  11. Cooperberg MR, Pasta DJ, Elkin EP, et al. The University of California, San Francisco cancer of the prostate risk assessment score: A straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005;173:1938–1942
  12. Cooperberg MR, Broering JM, Carroll PR. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst. 2009;101:878–887
  13. Cooperberg MR, Freedland SJ, Pasta DJ, et al. Multi-institutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cancer. 2006;107:2384–2391
  14. May M, Knoll N, Siegsmund M, et al. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a European multicenter survey of 1,296 patients. J Urol. 2007;178:1957–1962
  15. Zhao KH, Hernandez DJ, Han M, et al. External validation of University of California, San Francisco, cancer of the prostate risk assessment score. Urology. 2008;72:396–400
  16. Kundu SD, Roehl KA, Eggener SE, et al. Potency, continence, and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol. 2004;172:2227–2231
  17. Suardi N, Porter CR, Reuther AM, et al. A nomogram predicting long-term biochemical recurrence after radical prostatectomy. Cancer. 2008;112:1254–1263
  18. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:269–274
  19. Mitchell JA, Cooperberg MR, Elkin EP, et al. Ability of two pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: Data from CaPSURE. J Urol. 2005;173:1126–1131
  20. Greene KL, Meng MV, Elkin EP, et al. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: Results from Cancer of the Prostate Strategic Urological Research Endeavour (CaPSURE). J Urol. 2004;171:2255–2259

☆ This study was supported in part by the Urological Research Foundation, Prostate SPORE grant (P50 CA90386-05S2), and the Robert H. Lurie Comprehensive Cancer Center grant (P30 CA60553).

PII: S1078-1439(10)00166-3

doi: 10.1016/j.urolonc.2010.06.007

« Back Urologic Oncology: Seminars and Original Investigations

Article in Press

Article Tools

* Image Usage & Resolution